SCHEMBL3037573

SCHEMBL3037573

O=C1CN(C(=O)c2ccccc2)c2ccccc2-c2ccccc21

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNN4 O15554 5/20 0.78
KCNA3 P22001 5/20 0.78
NOTUM Q6P988 1/20 0.58
HTT P42858 2/20 0.54
ALDH1A1 P00352 6/20 0.47
HPGD P15428 1/20 0.47
RAB9A P51151 2/20 0.45
NPC1 O15118 1/20 0.45
PPARG P37231 1/20 0.45
NCOA2 Q15596 1/20 0.45
NCOA1 Q15788 1/20 0.45
LMNA P02545 3/20 0.42
USP2 O75604 1/20 0.42
TP53 P04637 1/20 0.42
TSHR P16473 1/20 0.42
ACHE P22303 1/20 0.41
BACE1 P56817 1/20 0.41
POLB P06746 1/20 0.40
AVPR2 P30518 1/20 0.40
AVPR1A P37288 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL68111 0.93 KCNN4 (0.68) KCNN4KCNA3NOTUMHTTALDH1A1
SCHEMBL3042508 0.88 KCNN4 (1.00) KCNN4KCNA3NOTUMHTTALDH1A1
SCHEMBL3042308 0.84 KCNA3 (1.00) KCNN4KCNA3NOTUMALDH1A1USP2
SCHEMBL3044124 0.83 KCNN4 (0.68) KCNN4KCNA3NOTUMHTTALDH1A1
SCHEMBL3034521 0.81 KCNN4 (0.61) KCNN4KCNA3NOTUMALDH1A1HPGD
SCHEMBL7003872 0.78 NOTUM (0.73) KCNN4KCNA3NOTUMHTTALDH1A1
SCHEMBL842907 0.77 HPGD (0.64) KCNN4KCNA3NOTUMHTTALDH1A1
SCHEMBL1495885 0.76 ALDH1A1 (0.58) HTTALDH1A1HPGDRAB9ALMNA
SCHEMBL1048074 0.74 NOTUM (1.00) KCNN4KCNA3NOTUMHTTALDH1A1
SCHEMBL30003296 0.74 NOTUM (1.00) KCNN4KCNA3NOTUMHTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100216772-A1 Novel Phenantridine Analogues and Uses Thereof 4SC AG (DE) 2010-08-26 US disclosed
EP-1740548-A1 NOVEL PHENANTRIDINE ANALOGUES AND THEIR USES AS INHIBITORS OF HYPERPROLIFERATION OF T CELLS AND/OR KERATINOCYTES 4SC AG (DE) 2007-01-10 EP disclosed
WO-2005105752-A1 NOVEL PHENANTRIDINE ANALOGUES AND THEIR USES AS INHIBITORS OF HYPERPROLIFERATION OF T CELLS AND/OR KERATINOCYTES 4SC AG (DE) 2005-11-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100216772-A1 Novel Phenantridine Analogues and Uses Thereof P2RX4, P2RX5, CLIC4 KCNN4 50/4885KCNA3 52/4885NOTUM 4130/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.